OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-BCHE antibodies

Anti-BCHE CONJUGATED Antibody Clone OTI4C12

TrueMAB™ Antibodies - Made against Authentic Protein Antigens

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA502288S BCHE (Butyrylcholinesterase) mouse monoclonal antibody, clone 4C12 30ul $120 In Stock
CF502288 Carrier-free (BSA/glycerol-free) BCHE mouse monoclonal antibody, clone OTI4C12 (formerly 4C12) 30ulug $450 3-4 weeks
Add to Shopping Cart
spacer

OriGene Data

ImmunogenFull length human recombinant protein of human BCHE (NP_000046) produced in HEK293T cell.
Clone NameClone OTI4C12 IsotypeIgG1
Species ReactivityHuman Concentration0.5 mg/ml
Guaranteed Application * Suggested Dilutions
Predicted MW Explanation 68.2 kDa
Buffer
Purification Purified from mouse ascites fluids by affinity chromatography

Reference Data

Target NameHomo sapiens butyrylcholinesterase (BCHE)
Alternative NameCHE1; CHE2; E1
Database LinkNP_000046
FunctionMutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage. [provided by RefSeq].
Related PathwayTransmembraneDruggable Genome

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title